FootSecure, a healthcare start-up specializing in podiatric medicine and wound care, has launched a state-of-the-art custom footwear manufacturing unit in Bangalore. This new venture, supported by the Karnataka Institute of Endocrinology & Research, marks a significant milestone in FootSecure’s mission to revolutionize foot care by providing tailored solutions for various foot conditions and reducing amputation rates through timely intervention.
According to research by Allied Market Research, the global diabetic footwear market was valued at $5,802.5 million in 2020 and is projected to reach $14,183.7 million by 2031, registering a CAGR of 7.9% from 2022 to 2031. This growth is driven by the increasing prevalence of chronic diseases like diabetes, arthritis, and plantar fasciitis, alongside advancements in medical technology.
Founded in 2018, FootSecure aims to make quality podiatric services affordable and accessible. The new Custom Prescription Footwear manufacturing facility in Bangalore is a testament to this mission. Speaking about the venture, Dr. Sanjay Sharma, Co-Founder of FootSecure, highlighted the lack of awareness about podiatry and therapeutic footwear in India. He emphasized that many available options do not meet therapeutic standards, often causing more harm than good.
“Many people believe that the softer the soles, the better the footwear. However, that is a myth. What a lot of patients need is an insole, which is hard enough to correct the foot position and the gait and withstand the body weight,” Dr. Sharma explained. He stressed the importance of bespoke footwear for pathological feet, which standard off-the-shelf products cannot adequately address.
FootSecure offers diagnosis, treatments, and surgeries for over 300 foot and ankle conditions, including chronic wounds and sports injuries. Its clinics and podiatry departments within hospitals provide effective care for foot, ankle, nail, and other below-knee conditions. With the launch of the prescription footwear manufacturing facility, FootSecure enhances its capability to offer integrated specialized foot health solutions.
“We are thrilled to launch our prescription footwear manufacturing unit,” said Dr. Sharma. “This represents a significant step forward in our mission to provide tailored foot care solutions. We are grateful for the support of the Karnataka Institute of Endocrinology & Research. Good quality, affordable, and well-designed prescription footwear can reduce pain, improve healing, enhance mobility, and drastically improve the quality of life for patients with various foot conditions.”
Set up with an initial investment of INR 30 Lakhs, the facility offers custom-designed footwear based on the pathology and biomechanics of the foot, ensuring stability, injury prevention, and comfort. FootSecure currently offers six models, with four options for women and two for men, starting from INR 2000/- onwards. The facility can produce up to 300 pairs of custom offloading footwear per day. By September, FootSecure aims to launch an app for customers and clinicians nationwide to upload their requirements for custom footwear.
FootSecure also has a proprietary digital ecosystem, including Wound360 and Foot360, which empowers healthcare providers with diagnostic guidelines, treatment support, and rehabilitation resources. These solutions integrate diagnostic devices, AI-enabled chatbots, mobile triage, and tele-podiatry to facilitate comprehensive foot health and wound care management.
Looking ahead, FootSecure plans to expand into new geographies and introduce innovative solutions, services, and products. By 2025, the company aims to establish India’s first dedicated podiatry hospital and launch a brand of specialized therapeutic footwear designed by medical experts from India and Australia.
FootSecure is a healthcare start-up specializing in podiatric medicine and wound care. FootSecure addresses chronic wounds and foot and ankle conditions through a phygital podiatry platform with advanced solutions for patients and clinicians. FootSecure’s mission includes expanding services, launching dedicated podiatry hospitals, and introducing specialized therapeutic footwear, positioning itself as India’s leading provider of lower limb and wound care solutions by 2025.
